Provided by Tiger Trade Technology Pte. Ltd.

Ashland

63.27
-1.5300-2.36%
Volume:342.35K
Turnover:21.62M
Market Cap:2.90B
PE:-4.18
High:64.32
Open:63.71
Low:62.19
Close:64.80
52wk High:66.40
52wk Low:45.21
Shares:45.76M
Float Shares:41.77M
Volume Ratio:0.55
T/O Rate:0.82%
Dividend:1.65
Dividend Rate:2.61%
EPS(TTM):-15.1257
EPS(LYR):-18.3696
ROE:-29.98%
ROA:2.09%
PB:1.54
PE(LYR):-3.44

Loading ...

Ashland Reports Fourth Quarter Fiscal 2025 Results and Issues Outlook for Full-Year 2026

THOMSON REUTERS
·
Nov 05, 2025

Press Release: Ashland reports fourth quarter fiscal 2025 results and issues outlook for full-year 2026

Dow Jones
·
Nov 05, 2025

Kura Oncology Reports Third Quarter 2025 Financial Results

GlobeNewswire
·
Nov 04, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 04, 2025

Dizal (Jiangsu) Pharmaceutical Co., Ltd. (688192.SH): Multiple Studies on Golidocitinib and Birelentinib Selected for 67th ASH Annual Meeting

Stock News
·
Nov 04, 2025

Oral Presentation: Five Hematologic Malignancies Studies by Leads Biolabs to Be Featured at ASH 2025

prnewswire
·
Nov 04, 2025

Ascentage Pharma to Present Data from Two Clinical Studies for Bcl-2 Inhibitor Lisaftoclax, Including an Oral Report, at ASH 2025

GlobeNewswire
·
Nov 04, 2025

Ascentage Pharma to Present Data from Multiple Studies of Olverembatinib, Including the First Dataset from POLARIS-1 Study, at ASH 2025

GlobeNewswire
·
Nov 04, 2025

Ascentage Pharma to Showcase Latest Clinical Study Results at ASH 2025

TIPRANKS
·
Nov 04, 2025

ASCENTAGE-B (06855) to Showcase Multiple Clinical Advances of Olverembatinib (Nerlynx®), Lisaftoclax (Lisenla®), and APG-5918 at 2025 ASH Annual Meeting, Including One Oral Presentation

Stock News
·
Nov 04, 2025

Imugene Announces Webinar on CAR T Naïve Lymphomas and ASH Presentation

TIPRANKS
·
Nov 04, 2025

Imugene’s Azer-cel Selected for Prestigious ASH Presentation

TIPRANKS
·
Nov 04, 2025

Nanjing Leads Biolabs to Present Key Research at ASH Annual Meeting

TIPRANKS
·
Nov 04, 2025

LEADS BIOLABS-B (09887): LBL-034 Clinical Study Selected as First Oral Presentation on Opening Day of 67th ASH Annual Meeting

Stock News
·
Nov 04, 2025

Legend Biotech to Showcase Key Research at ASH 2025

TIPRANKS
·
Nov 04, 2025

Arvinas to Present Preclinical Data for ARV-393 at the 2025 American Society of Hematology (ASH) Annual Meeting

GlobeNewswire
·
Nov 04, 2025

Active Biotech to Present Promising Tasquinimod Data at ASH 2025

TIPRANKS
·
Nov 04, 2025

Oncopeptides’ NK Cell Engager Study to be Presented at ASH

TIPRANKS
·
Nov 03, 2025

BioInvent to Present Promising Phase 2a Data at ASH 2025

TIPRANKS
·
Nov 03, 2025

Autolus Therapeutics to present data at ASH Meeting

TIPRANKS
·
Nov 03, 2025